Back to Search
Start Over
Quality and risk of bias appraisals of systematic reviews are inconsistent across reviewers and centers
- Publication Year :
- 2020
- Publisher :
- Elsevier, 2020.
-
Abstract
- © 2020 The Authors. Published by Elsevier Inc. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).<br />Objective: The objective of the study was to evaluate the inter-rater and intercenter reliability, usability, and utility of A MeaSurement Tool to Assess systematic Reviews (AMSTAR), AMSTAR 2, and Risk Of Bias In Systematic reviews (ROBIS). Study design and setting: This is a prospective evaluation using 30 systematic reviews of randomized trials, undertaken at three international centers. Results: Reviewers completed AMSTAR, AMSTAR 2, and ROBIS in median (interquartile range) 15.7 (11.3), 19.7 (12.1), and 28.7 (17.4) minutes and reached consensus in 2.6 (3.2), 4.6 (5.3), and 10.9 (10.8) minutes, respectively. Across all centers, inter-rater reliability was substantial to almost perfect for 8/11 AMSTAR, 9/16 AMSTAR 2, and 12/24 ROBIS items. Intercenter reliability was substantial to almost perfect for 6/11 AMSTAR, 12/16 AMSTAR 2, and 7/24 ROBIS items. Intercenter reliability for confidence in the results of the review or overall risk of bias was moderate (Gwet's first-order agreement coefficient (AC1) 0.58, 95% confidence intervals [CI]: 0.30 to 0.85) to substantial (AC1 0.74, 95% CI: 0.30 to 0.85) for AMSTAR 2 and poor (AC1 -0.21, 95% CI: -0.55 to 0.13) to moderate (AC1 0.56, 95% CI: 0.30 to 0.83) for ROBIS. It is not clear whether using the appraisals of any tool as an inclusion criterion would alter an overview's findings. Conclusions: Improved guidance may be needed to facilitate the consistent interpretation and application of the newer tools (especially ROBIS).
- Subjects :
- Quality Control
medicine.medical_specialty
Epidemiology
media_common.quotation_subject
Prospective evaluation
law.invention
03 medical and health sciences
0302 clinical medicine
Bias
Randomized controlled trial
law
Humans
Medicine
Quality (business)
Prospective Studies
030212 general & internal medicine
Methodological quality
Reliability (statistics)
media_common
Observer Variation
AMSTAR
Evidence-Based Medicine
business.industry
AMSTAR 2
Reproducibility of Results
Systematic reviews
Risk of bias
Confidence interval
ROBIS
Systematic review
Physical therapy
business
030217 neurology & neurosurgery
Systematic Reviews as Topic
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b2d0f632ffa375e1bf08ba805bea56d9